Page 571 - Multidisipliner Covid 19
P. 571
COVID-19 Pandemisi ve Kalp-Damar Sistemi
al. SARS-koronaviru_s modulation of myocardial ACE2 expres- sion
and inflammation in patients with SARS. Eur J Clin Invest 2009;39:
618–25.
22. Zeng JH, Liu Y, Yuan J, Wang F, Wu W, et al. First Case of COVID-19
Infection with Fulminant Myocarditis Complication: CaseReport and
Insights. Preprints Mar 11, 2020. [Epub ahead of print], doi: 10.20944/
preprints 2020.03.0180.v1.
23. WF, Tang X, Zhao XX. An ‘asymptomatic’ driver with COVID-19:
atypical suspected myocarditis by SARS-CoV-2. 2020.Available at:
file:///Users/minideniz/Downloads/cdt-10-02-242.pdf. Accessed
Apr 27
24. Ma KL, Liu ZH, Cao CF, Liu MK, Liao J, Zou JB, et al. COVID-19
Myocarditis and Severity Factors: An Adult Cohort Study. MedRxiv
2020 MAR 19. [Epub ahead of print], doi: https://doi.org/10.1101/
2020.03.19.20034124.
25. Alida LP, Pankuweit S, Arbustini E, et al. Cur- rent state of knowledge
on aetiology, diagnosis,management, and therapy of myocarditis: a
position statement of the European society of cardiology Working
Group on Myocardial and Pericardial Disease. Eur Heart J. 2013;34:
2636-48.
26. McMurray JJ, Adamopoulos S, Anker SD, et al. ESC guidelines for
the diagnosis and treat- ment of acute and chronic heart failure 2012:
the Task Force for the diagnosis and treat- ment of acute and chronic
heart failure 2012 of the European Society of Cardiology. Devel- oped
in collaboration with the Heart Failure Association of the ESC (HFA).
Eur Heart J. 2012;33:1787-847.
27. ESC Guidance for the Diagnosis and Management of CV Disease dur-
ing the COVID-19 Pandemic Last updated on 21 April 2020. © The
European Society of Cardiology.
28. Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, Wang B, Xiang H, Cheng
Z, Xiong Y, Zhao Y, Li Y, Wang X, Peng Z. Clinical Characteristicsof
138 Hospitalized Patients With 2019 Novel Coronavirus-Infected
Pneumonia in Wuhan, China. JAMA 2020 Feb 7. [Epub
ahead of print], doi: 10.1001/jama.2020.1585.
29. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features
of patients infected with 2019 novel coronavirus in Wuhan, China.
Lancet 2020;395:497–506.
570